The company will soon apply to extend their emergency use authorization for this age group in the U.S and other countries.
In a press release earlier today, Pfizer and BioNTech announced results from their Phase 3 study of 2,260 adolescents ages 12-15.
Key results:
➡️ There were 18 cases of COVID-19 in the trial….. ALL in the placebo group.
➡️ That’s a big fat ZERO in the vaccine group!!
➡️ Neutralizing antibody levels to SARS-CoV-2 measured in the blood of vaccine recipients were as high or higher than those seen for those ages 16-25 in previous studies.
➡️ The vaccine was “well-tolerated”- side effects similar to other age groups.
⚠️ Caveat: This is still a press release, not the full data. But it’s hard to fudge ZERO cases in the vaccine group, so we’re optimistic there won’t be any surprises.
TL;DR: It’s GREAT news that an approved vaccine is effective and may soon be available for kids 12 and over.
This is one important step closer to BOTH protecting our kids from illness AND getting our populations closer to herd immunity which protects everyone.
Love,
Those Nerdy Girls
Links:
